REFERENCES
1. Marcovina SM, Crea F, Davignon J, Kaski JC, Koenig W, et al. Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools. J Int Med 2007;261:214-34.
2. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, et al. American society of echocardiography carotid intima-media thickness task force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American society of echocardiography carotid intima-media thickness task force. Endorsed by the society for vascular medicine. J Am Soc Echocardiogr 2008;21:93-111.
3. Amato M, Montrosi P, Ravani A, Oldani E, Galli S, et al. Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings. Eur Heart J 2007;28:2094-101.
4. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) study, 1987-1993. Am J Epidemiol 1997;146:483-94.
5. Baldassarre D, Nyyssönen K, Rauramaa R, de Faire U, Hamsten A, et al; IMPROVE study group. Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study. Eur Heart J 2010;31:614-22.
6. D'Agostino RB, Pencina MJ, Massaro JM, Coady S. Cardiovascular disease risk assessment: insights from Framingham. Glob Heart 2013;8:11-23.
7. Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Belder R, et al; Kuopio atherosclerosis prevention study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995;92:1758-64.
8. Beux F, Carmassi S, Salvetti MV, Ghiadoni L, Huang Y, et al. Automatic evaluation of arterial diameter variation from vascular echographic images. Ultrasound Med Biol 2001;27:1621-9.
9. Sobenin IA, Sazonova MA, Postnov AY, Salonen JT, Bobryshev YV, et al. Association of mitochondrial genetic variation with carotid atherosclerosis. PLoS One 2013;8:e68070.
10. Sazonova M, Budnikov E, Khasanova Z, Sobenin I, Postnov A, et al. Studies of the human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome. Atherosclerosis 2009;204:184-90.
11. Sobenin IA, Sazonova MA, Postnov AY, Bobryshev YV, Orekhov AN. Mitochondrial mutations are associated with atherosclerotic lesions in the human aorta. Clin Dev Immunol 2012;2012:832464.
12. Lang TA, Secic M. How to report statistics in medicine: annotated guidelines for authors, editors, and reviewers Second edition. Philadelphia: American College of Physicians; 2006.
13. Ioannidis JP. Prediction of cardiovascular disease outcomes and established cardiovascular risk factors by genome-wide association markers. Circ Cardiovasc Genet 2009;2:7-15.
14. Sobenin IA, Chistiakov DA, Bobryshev YV, Postnov AY, Orekhov AN. Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications. Curr Pharm Des 2013;19:5942-53.
16. Sobenin IA, Zhelankin AV, Mitrofanov KY, Sinyov VV, Sazonova MA, et al. Mutations of mitochondrial DNA in atherosclerosis and atherosclerosis-related diseases. Curr Pharm Des 2015;21:1158-63.
17. Sobenin IA, Zhelankin AV, Sinyov VV, Bobryshev YV, Orekhov AN. Mitochondrial aging: focus on mitochondrial DNA damage in atherosclerosis - A mini-review. Gerontology 2015;61:343-9.
18. Sinyov VV, Sazonova MA, Ryzhkova AI, Galitsyna EV, Melnichenko AA, et al. Potential use of buccal epithelium for genetic diagnosis of atherosclerosis using mtDNA mutations. Vessel Plus 2017;1:145-50.
19. Sazonova MA, Ryzhkova AI, Sinyov VV, Galitsyna EV, Orekhova VA, et al. New markers of atherosclerosis: a threshold level of heteroplasmy in mtDNA mutations. Vessel Plus 2017;1:182-91.
20. Hoffmann B, Moebus S, Dragano N, Möhlenkamp S, Memmesheimer M, et al. Heinz nixdorf recall investigative group. Residential traffic exposure and coronary heart disease: results from the Heinz Nixdorf Recall Study. Biomarkers 2009;14:74-8.